Legal

Terms of Service

Last Updated: May 26, 2026

Welcome to Aevius Labs. These Terms of Service (these “Terms”) are a legal agreement between Aevius Labs, Inc., a Delaware corporation (“Aevius,” “we,” “us,” or “our”), and the individual or entity accessing or using the Platform (“you” or “your”).

These Terms govern your access to and use of Aevius websites, online services, software, APIs, artificial intelligence features, demos, documentation, evaluation environments, communications, and related products and services that link to these Terms (collectively, the “Platform”). If you access or use the Platform on behalf of a company, institution, or other organization, you represent that you have authority to bind that organization, and “you” includes that organization.

These Terms are the public baseline terms for the Platform. Enterprise deployments, customer workspaces, paid products, partner arrangements, data processing, protected health information, regulated use, commercial product rights, and other special use cases may require a separate written agreement, order form, data processing addendum, business associate agreement, product addendum, partner agreement, or similar written terms (each, an “Additional Agreement”). If an Additional Agreement applies, it controls for the services, data, and use cases covered by that Additional Agreement to the extent of any conflict with these Terms.

PLEASE READ THESE TERMS CAREFULLY. BY ACCESSING OR USING THE PLATFORM, CLICKING TO ACCEPT THESE TERMS, OR OTHERWISE INDICATING ACCEPTANCE, YOU AGREE TO BE BOUND BY THESE TERMS. IF YOU DO NOT AGREE, DO NOT ACCESS OR USE THE PLATFORM.

SECTION 22 CONTAINS AN ARBITRATION AGREEMENT AND CLASS ACTION WAIVER. IT AFFECTS HOW DISPUTES ARE RESOLVED. PLEASE READ IT CAREFULLY.

1. Definitions

“AI Features” means artificial intelligence, machine learning, retrieval, analytics, automation, generative, or other model-enabled functionality made available through the Platform.

“Content” means text, data, files, images, documents, code, prompts, outputs, analyses, comments, materials, and other information available through, submitted to, or generated by the Platform.

“Customer Content” means Content that you or your authorized users submit to, upload to, connect to, configure for, or generate through the Platform, including prompts, queries, files, datasets, metadata, annotations, configurations, and outputs generated specifically from your inputs.

“Customer Environment” means a system, workspace, account, tenant, platform, or environment controlled by you, your organization, or a third party authorized by you or your organization.

“Documentation” means user guides, technical documentation, product descriptions, policies, notices, and other materials Aevius provides for the Platform.

“Model Package” means an Aevius-controlled model, model artifact, configuration, software component, tool, or related technical package made available through the Platform or an Additional Agreement.

“Order” means an order form, statement of work, online checkout, written subscription plan, or other ordering document accepted by Aevius.

“Services” means the products, services, features, and functionality made available through the Platform.

“Usage Data” means technical, operational, and usage information about use of the Platform, such as logs, timestamps, account identifiers, usage events, performance information, feature usage, diagnostics, and security signals, excluding Customer Content itself.

2. Eligibility and Authority

You must be at least 18 years old and able to form a binding contract to use the Platform. You may not use the Platform if you are barred from doing so under applicable law, located in a jurisdiction subject to comprehensive U.S. sanctions, or listed on a restricted party list.

If you use the Platform on behalf of an organization, you represent and warrant that you have authority to accept these Terms on that organization’s behalf and that your use complies with that organization’s policies and authorizations.

3. Changes to the Platform or Terms

We may modify, suspend, or discontinue all or part of the Platform at any time. We may also update these Terms from time to time. If we make material changes, we will update the “Last Updated” date above and provide any additional notice required by law. Changes are effective when posted unless a later effective date is stated. Your continued use of the Platform after changes take effect means you accept the updated Terms.

4. Accounts and Organization Administration

Some Platform features may require an account. You must provide accurate, current, and complete account information and keep it updated. You are responsible for maintaining the confidentiality of your credentials and for all activity under your account. You must promptly notify Aevius if you believe your account or credentials have been compromised.

If your account is provided by or associated with an organization, that organization and its administrators may be able to manage your account, configure permissions, access Usage Data, control access to Customer Content, and enforce organization policies according to the applicable agreement and settings.

5. Access Rights

Subject to your compliance with these Terms and any applicable Order, Aevius grants you a limited, non-exclusive, non-transferable, revocable right to access and use the Platform for your internal business, non-production evaluation, research that does not affect individuals or require institutional approval, or other authorized purposes during the applicable term. You receive no rights except those expressly granted in these Terms or an Additional Agreement.

You must use the Platform only in accordance with these Terms, the Documentation, applicable law, and any usage limits, technical restrictions, access controls, product notices, or product-specific terms we provide.

6. Public, Demo, Evaluation, and Beta Use

Public websites, demos, free trials, previews, pilots, proof-of-concepts, sandboxes, and evaluation features (collectively, “Evaluation Offerings”) are provided for non-production evaluation only unless Aevius states otherwise in an Additional Agreement. Evaluation Offerings may be incomplete, may change or stop at any time, may not be generally released, and may be subject to additional terms.

Unless expressly authorized in an Additional Agreement, Evaluation Offerings must not be used with production data, protected health information, patient-identifiable information, sensitive personal information, regulated data, confidential third-party data, or data that you are not authorized to provide. Evaluation Offerings are provided “as is,” without warranties, service levels, support commitments, indemnities, or obligations to retain Customer Content.

Evaluation Offerings are not for clinical, interventional, patient-impacting, or production research use. Human-subject research, patient outreach, patient selection, patient contact, publication using customer or patient-level data, or return of individual-level results requires an Additional Agreement and all required institutional, ethical, privacy, and regulatory approvals.

7. Enterprise and Customer Environment Deployments

Some Services may operate in or connect to a Customer Environment. You are responsible for the Customer Environment, including data rights, permissions, access controls, configurations, identity management, security settings, retention settings, audit logs, and approvals required for your use.

If you authorize Aevius or the Platform to access, process, analyze, or generate Content in a Customer Environment, you represent that you have all rights, consents, approvals, and authority necessary for that access and processing. Aevius is not responsible for unauthorized access or processing caused by your configuration, credentials, permissions, data-sharing choices, third-party systems, or failure to follow the Documentation.

You are responsible for data classification, entitlements, routing, approvals, and other controls in any Customer Environment. Aevius is responsible only for controls under Aevius’s control as described in the applicable Additional Agreement, security terms, data processing addendum, or business associate agreement. Unless an Additional Agreement expressly says otherwise, Aevius has no duty to inspect Customer Environments for improper data routing, improper permissions, or unauthorized sensitive data.

8. Healthcare Data and Sensitive Data

Unless expressly authorized in an Additional Agreement, you must not submit, upload, connect, transmit, or otherwise make available to the Platform any protected health information, patient-identifiable information, regulated health data, financial account information, government identifiers, biometric identifiers, children’s data, or other sensitive personal information.

If an Additional Agreement authorizes processing of protected health information, regulated health data, or other sensitive data, you must comply with that Additional Agreement, applicable law, required consents and authorizations, minimum necessary principles where applicable, data-use limitations, security requirements, institutional approvals, and all required flow-down terms.

Aevius is not acting as a business associate under these public Terms alone and does not agree under these public Terms to receive, create, maintain, or transmit protected health information. Any business associate relationship must be expressly set out in a business associate agreement signed by an authorized Aevius representative.

If you provide protected health information, patient-identifiable information, regulated health data, or other sensitive data without authorization, Aevius may delete, quarantine, restrict, or suspend processing of that data, and you must notify Aevius promptly and cooperate with any required remediation.

If you provide deidentified data, you represent that the data has been deidentified in accordance with applicable law, that you have documented the applicable deidentification method where required, and that you will not provide a reidentification key or attempt to reidentify individuals unless expressly authorized by law and by the applicable Additional Agreement. Limited data sets, pseudonymized data, coded data, tokenized data, and other data that remains reasonably linkable to an individual are not treated as deidentified data under these Terms unless the applicable Additional Agreement expressly says so. Derived outputs, features, metadata, and other results may remain subject to the same contractual controls as the underlying data if they are reasonably linkable to an individual or data subject.

9. Acceptable Use

You agree not to, and not to allow others to:

• Use the Platform in violation of applicable law, these Terms, Documentation, or third-party rights.
• Submit, upload, transmit, or process unlawful, infringing, defamatory, deceptive, harassing, abusive, obscene, or otherwise harmful Content.
• Submit malicious code, malware, viruses, worms, or other harmful software.
• Interfere with, disrupt, overload, damage, or impair the Platform or any networks, systems, or infrastructure used to provide it.
• Attempt to gain unauthorized access to the Platform, accounts, systems, data, models, Customer Environments, or networks.
• Probe, scan, penetration test, or vulnerability test the Platform without Aevius’s prior written authorization.
• Reverse engineer, decompile, disassemble, copy, modify, or create derivative works of the Platform except to the extent applicable law prohibits this restriction.
• Scrape, crawl, harvest, extract, or use automated means to access the Platform except as expressly authorized by Aevius.
• Benchmark, monitor, or analyze the Platform for competitive purposes or publish performance information without Aevius’s prior written consent.
• Use the Platform to develop, train, improve, or validate a competing product, model, dataset, or service.
• Attempt to extract, infer, copy, or reconstruct model weights, embeddings, system prompts, training data, evaluation data, source code, architecture, non-public configurations, or other non-public components of the Platform.
• Remove, obscure, or alter proprietary notices.
• Sell, resell, sublicense, rent, lease, lend, distribute, timeshare, service-bureau, or make the Platform available to third parties except as expressly authorized.
• Use the Platform for high-risk, safety-critical, or regulated decisions where failure could lead to death, personal injury, severe property damage, significant legal impact, significant financial impact, or denial of essential services unless expressly authorized in an Additional Agreement.
• Use the Platform for diagnosis, treatment, patient care, triage, patient management, patient selection, clinical decision support, medical advice, or any healthcare decision affecting an individual unless expressly authorized in an Additional Agreement that covers the specific intended use and required safeguards.
• Use the Platform to create weapons, facilitate illegal conduct, violate privacy rights, unlawfully discriminate, or make decisions that unlawfully affect individuals’ rights or access to services.

Aevius may investigate suspected violations and may suspend or terminate access to the Platform if we reasonably believe you have violated these Terms or created risk for Aevius, users, customers, third parties, or the Platform.

10. Customer Content

As between you and Aevius, you retain ownership of Customer Content. You grant Aevius and its service providers a non-exclusive, worldwide, royalty-free license to host, copy, process, transmit, display, modify, and use Customer Content only as necessary to provide, secure, support, maintain, troubleshoot, monitor, meter, and operate the Services you use; comply with law; enforce these Terms; and fulfill any applicable Order or Additional Agreement.

Aevius will not use Customer Content to train, fine-tune, or improve models except as expressly permitted by an Additional Agreement, product-specific terms, or documented consent. Aevius will not use Customer Content containing protected health information, regulated health data, sensitive personal information, or customer confidential information for model training, model development, cross-customer benchmarking, or product improvement except as expressly authorized in an applicable Additional Agreement. Aevius may use Usage Data and aggregated, deidentified, or other non-personal information for analytics, security, research, development, operations, and business purposes, provided it does not identify you, your organization, or any individual.

You represent and warrant that you have all rights, consents, permissions, approvals, and authority necessary to provide Customer Content to Aevius and to grant the rights described in these Terms. You are responsible for Customer Content, including its accuracy, legality, quality, integrity, rights status, and compliance with applicable law.

11. AI Features, Model Packages, and Outputs

AI Features may generate outputs based on Customer Content, prompts, model behavior, retrieved information, configurations, and other inputs. You acknowledge and agree that:

• Outputs may be inaccurate, incomplete, misleading, biased, outdated, or unsuitable for your intended use.
• Outputs may appear plausible even when they are wrong.
• Similar or identical outputs may be generated for other users.
• Outputs may require independent verification, human review, validation, and oversight.
• Aevius does not guarantee that outputs are correct, complete, current, unique, protectable, or free from third-party rights.
• You are responsible for determining whether outputs are appropriate for your use case and for all decisions, actions, products, or workflows based on outputs.

As between you and Aevius, and subject to your compliance with these Terms, any applicable Additional Agreement, and third-party rights, you may use outputs generated specifically from your Customer Content for your authorized purposes. Aevius retains all rights in and to the Platform, Services, AI Features, Model Packages, models, software, systems, methods, workflows, tools, configurations, Documentation, Usage Data, and underlying technology.

Aevius may update, modify, improve, replace, or discontinue AI Features and Model Packages from time to time. Specific commitments relating to versions, changes, validation, documentation, intended-use restrictions, or regulated-use support apply only if expressly stated in an Additional Agreement.

12. Commercial Rights and Third-Party Use

Your access to the Platform does not grant you any right to commercialize, resell, sublicense, distribute, externally expose, or make available any Aevius technology, Model Package, API, output, workflow, application, product, service, or other offering based on the Platform.

Unless expressly authorized in an Additional Agreement, you may not:

• Build or offer a third-party-facing product or service that depends on the Platform.
• Use the Platform to provide services to third parties as a service bureau, managed service, or outsourced processing service.
• Package, validate, certify, label, market, or distribute any output, workflow, application, product, or service as a clinical, regulated, diagnostic, therapeutic, or decision-support offering.
• Grant any third party access to the Platform, Model Packages, outputs, Usage Data, Customer Content, or Customer Environment except as expressly permitted by your account settings and applicable agreement.

Separate commercial, validation, support, and regulated-use terms may apply where Aevius authorizes these activities.

13. Healthcare, Medical, and Regulatory Disclaimers

Aevius is not a medical provider and does not provide medical advice, diagnosis, treatment, or patient care. Unless Aevius expressly states otherwise in an Additional Agreement, the Platform is provided for business, non-clinical research, analytics, development, evaluation, and related non-clinical purposes only.

The Platform is not a substitute for professional medical judgment. Unless expressly authorized in an Additional Agreement that covers the specific intended use and required safeguards, you must not use the Platform for diagnosis, treatment, patient management, medical advice, clinical decision-making, triage, patient selection, clinical decision support, or any healthcare decision that could affect an individual’s care.

Unless expressly stated in an Additional Agreement, the Platform has not been cleared, approved, authorized, certified, or otherwise reviewed by the U.S. Food and Drug Administration or any other healthcare regulator for clinical care delivery or as a medical device. Any clinical, regulated, or patient-impacting use requires a separate written agreement addressing the applicable intended use, user population, patient population, validation responsibilities, labeling and claims, change control, quality-system responsibilities, monitoring, regulatory responsibility, and other required safeguards. You are solely responsible for determining whether your use requires regulatory authorization, clinical validation, institutional approval, privacy review, security review, ethics review, quality-system controls, or other safeguards.

The Platform is not fault tolerant and is not designed or intended for use in environments where failure could lead directly to death, personal injury, severe property damage, severe environmental damage, or denial of essential services.

14. Third-Party Services

The Platform may interoperate with or be made available through third-party services, platforms, identity providers, infrastructure providers, AI providers, payment processors, or other third-party products or services (“Third-Party Services”). Third-Party Services are not controlled by Aevius and may be subject to separate terms and privacy policies.

Aevius is not responsible for Third-Party Services, including their availability, security, functionality, content, or processing of information after it leaves the Platform. Your use of Third-Party Services is at your own risk and may require you to comply with third-party terms.

15. Fees, Payment, Metering, and Subscriptions

If you purchase paid Services, you agree to pay all fees, taxes, and charges described in the applicable Order. Fees may be based on access, usage, subscriptions, support, or other units described in the applicable Order. Fees are non-refundable except as expressly stated in the applicable Order or required by law.

If you provide a payment method, you authorize Aevius or its payment processor to charge that payment method for amounts due. If Services are provided on a subscription or recurring basis, the subscription will renew as stated in the applicable Order. Unless the applicable Order says otherwise, you must cancel before the renewal date to avoid renewal charges. Aevius may suspend or terminate access for late payment.

You may not circumvent metering, usage limits, access limits, pricing tiers, or technical controls. Purchases through third-party procurement channels may be subject to additional third-party terms, billing rules, taxes, credits, cancellation rules, or procurement terms.

16. Ownership and Intellectual Property

Aevius and its licensors retain all rights, title, and interest in and to the Platform, Services, Documentation, Model Packages, software, models, systems, methods, workflows, interfaces, designs, inventions, technology, know-how, trademarks, logos, and other intellectual property. No rights are granted except as expressly stated in these Terms or an Additional Agreement.

You may not use Aevius names, logos, trademarks, or service marks without Aevius’s prior written consent.

If you provide feedback, suggestions, ideas, requests, improvements, or recommendations about Aevius or the Platform (“Feedback”), you grant Aevius a perpetual, irrevocable, worldwide, royalty-free right to use, disclose, reproduce, license, distribute, and otherwise exploit the Feedback without restriction or compensation.

17. Confidentiality

If you receive non-public information about Aevius, the Platform, Evaluation Offerings, security practices, roadmap, pricing, performance, architecture, business plans, Model Packages, or technology, you must protect it using reasonable care and use it only for the purpose for which it was provided. You may not disclose it to third parties without Aevius’s prior written consent.

Do not submit confidential information to Aevius unless it is covered by a separate written confidentiality agreement or you are comfortable with Aevius using it under these Terms.

18. Privacy and Data Protection

Aevius’s Privacy Policy explains how Aevius collects, uses, and discloses personal information. By using the Platform, you acknowledge the Privacy Policy. If a data processing addendum, business associate agreement, or similar agreement is required for a particular use, it must be executed before the applicable data is submitted to or processed by Aevius.

19. Security

Aevius uses reasonable measures designed to protect the Platform. However, no system is perfectly secure. You are responsible for configuring your accounts, integrations, permissions, Customer Environments, and systems appropriately and for protecting your credentials.

20. Termination and Suspension

These Terms begin when you first access or use the Platform and continue until terminated. You may stop using the Platform at any time. Aevius may suspend or terminate your access to the Platform at any time if we reasonably believe you have violated these Terms, your use creates risk, your account is inactive, payment is overdue, an Additional Agreement expires or terminates, or suspension is necessary to protect the Platform, Aevius, users, customers, third parties, data, or systems.

Upon termination, your right to access and use the Platform ends immediately. You must stop using the Platform and delete any non-public Documentation or software in your possession, except as otherwise permitted by an Additional Agreement. Sections that by their nature should survive termination will survive, including sections on ownership, Customer Content, AI Features, commercialization rights, healthcare disclaimers, fees, confidentiality, disclaimers, indemnity, limitation of liability, dispute resolution, governing law, and general terms.

21. Disclaimers; Indemnity; Limitation of Liability

Disclaimers

TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE PLATFORM, SERVICES, DOCUMENTATION, CONTENT, AI FEATURES, OUTPUTS, MODEL PACKAGES, EVALUATION OFFERINGS, AND THIRD-PARTY SERVICES ARE PROVIDED “AS IS” AND “AS AVAILABLE.” AEVIUS DISCLAIMS ALL WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON-INFRINGEMENT, ACCURACY, AVAILABILITY, SECURITY, RELIABILITY, AND ERROR-FREE OPERATION.

AEVIUS DOES NOT WARRANT THAT THE PLATFORM WILL BE UNINTERRUPTED, SECURE, ACCURATE, COMPLETE, ERROR-FREE, OR COMPATIBLE WITH YOUR SYSTEMS OR REQUIREMENTS. AEVIUS DOES NOT WARRANT THAT ANY CONTENT, MODEL PACKAGE, AI FEATURE, OR OUTPUT WILL BE ACCURATE, COMPLETE, CURRENT, UNIQUE, VALIDATED, REGULATORY-COMPLIANT, OR SUITABLE FOR ANY PARTICULAR USE.

Indemnity

You will indemnify, defend, and hold harmless Aevius and its affiliates, officers, directors, employees, contractors, advisors, licensors, and service providers from and against any claims, losses, liabilities, damages, costs, and expenses, including reasonable attorneys’ fees, arising out of or relating to:

• Your access to or use of the Platform.
• Customer Content.
• Your violation of these Terms, an Additional Agreement, or applicable law.
• Your violation of third-party rights.
• Your use of outputs, AI Features, or Model Packages.
• Your use of the Platform with regulated, sensitive, clinical, or patient-related data without proper authorization.
• Your commercialization, sublicensing, regulated-product activity, or third-party access not expressly authorized by Aevius.
• Your Customer Environment, configurations, permissions, or third-party integrations.

Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, AEVIUS WILL NOT BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, PUNITIVE, OR ENHANCED DAMAGES, OR FOR LOST PROFITS, LOST REVENUE, LOST BUSINESS, LOST GOODWILL, LOST DATA, BUSINESS INTERRUPTION, OR COST OF SUBSTITUTE SERVICES, EVEN IF AEVIUS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

TO THE MAXIMUM EXTENT PERMITTED BY LAW, AEVIUS’S TOTAL LIABILITY ARISING OUT OF OR RELATING TO THESE TERMS OR THE PLATFORM WILL NOT EXCEED THE GREATER OF (A) $100 OR (B) THE AMOUNT YOU PAID TO AEVIUS FOR THE SERVICES GIVING RISE TO THE CLAIM IN THE 12 MONTHS BEFORE THE EVENT GIVING RISE TO LIABILITY.

The limitations in this section apply to all theories of liability, whether based in contract, tort, negligence, strict liability, statute, or otherwise. Some jurisdictions do not allow certain disclaimers or limitations, so some of the above may not apply to you.

22. Dispute Resolution; Arbitration; Class Waiver

Informal Resolution

Before filing a claim, you and Aevius agree to try to resolve the dispute informally. A party must send written notice describing the dispute and requested relief to the other party. Notices to Aevius must be sent to legal@aevius.ai. The parties will attempt in good faith to resolve the dispute for 30 days after notice is received.

Arbitration Agreement

Except for claims that may be brought in small claims court and claims seeking injunctive or equitable relief for intellectual property misuse, confidentiality breaches, security incidents, or unauthorized access, any dispute, claim, or controversy arising out of or relating to these Terms, the Platform, or your relationship with Aevius will be resolved by binding arbitration rather than in court.

The Federal Arbitration Act governs this arbitration agreement. Arbitration will be administered by the American Arbitration Association under its applicable rules. The arbitrator will have authority to resolve disputes regarding the interpretation, applicability, enforceability, and formation of this arbitration agreement. Judgment on the award may be entered in any court of competent jurisdiction.

Class Action Waiver

YOU AND AEVIUS AGREE THAT EACH MAY BRING CLAIMS AGAINST THE OTHER ONLY IN AN INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY CLASS, COLLECTIVE, REPRESENTATIVE, CONSOLIDATED, OR PRIVATE ATTORNEY GENERAL ACTION. The arbitrator may not consolidate claims of more than one person or entity unless all parties agree in writing.

Jury Trial Waiver

YOU AND AEVIUS WAIVE ANY RIGHT TO A JURY TRIAL TO THE MAXIMUM EXTENT PERMITTED BY LAW.

30-Day Opt Out

You may opt out of this arbitration agreement by sending written notice to legal@aevius.ai within 30 days after you first become subject to these Terms. Your notice must include your name, email address, organization if applicable, and a clear statement that you opt out of the arbitration agreement. Opting out does not affect any other part of these Terms.

Severability

If any part of this Section 22 is found unenforceable, the unenforceable part will be severed and the remaining parts will remain in effect, except that if the class action waiver is found unenforceable for a claim, that claim must proceed in court and not arbitration.

23. Governing Law and Venue

These Terms are governed by the laws of the State of Delaware, without regard to conflict of law principles, and by applicable federal law, including the Federal Arbitration Act. Subject to Section 22, the state and federal courts located in Delaware will have exclusive jurisdiction over disputes arising out of or relating to these Terms or the Platform, and you consent to personal jurisdiction and venue in those courts.

24. Copyright and Intellectual Property Complaints

If you believe Content on the Platform infringes your copyright or other intellectual property rights, you may send a notice to:

Aevius Labs, Inc.
Attn: Copyright Agent
Boston, Massachusetts, United States
Email: legal@aevius.ai

Your notice should include:

• Identification of the work you claim is infringed.
• Identification of the allegedly infringing material and where it is located.
• Your name, address, phone number, and email address.
• A statement that you have a good-faith belief that use of the material is not authorized by the owner, its agent, or the law.
• A statement that the information in the notice is accurate and, under penalty of perjury, that you are authorized to act on behalf of the owner.
• Your physical or electronic signature.

Aevius may remove or disable access to allegedly infringing material and may take other action in its discretion.

25. Notices

Aevius may provide notices by email, through the Platform, by posting on our website, or by other legally permitted means. Notices to Aevius must be sent to legal@aevius.ai unless an Additional Agreement provides another notice method.

26. General Terms

These Terms, together with any applicable Orders and policies referenced in them, are the entire agreement between you and Aevius regarding the Platform, unless an Additional Agreement applies. You may not assign or transfer these Terms without Aevius’s prior written consent. Aevius may assign these Terms in connection with a merger, acquisition, financing, reorganization, sale of assets, or by operation of law.

If any provision of these Terms is unenforceable, the remaining provisions will remain in effect and the unenforceable provision will be modified to the minimum extent necessary to make it enforceable. Aevius’s failure to enforce a provision is not a waiver. The words “including” and “includes” mean “including without limitation.” The parties are independent contractors, and these Terms do not create any agency, partnership, employment, fiduciary, or joint venture relationship.

27. Contact Information

Questions about these Terms may be sent to:

Aevius Labs, Inc.
Attn: Legal
Boston, Massachusetts, United States
Email: legal@aevius.ai
Phone: (978) 763-4608